| Systematic review: brain metastases from colorectal cancer—incidence and patient characteristics TD Christensen, KLG Spindler, JA Palshof, DL Nielsen BMC cancer 16, 1-14, 2016 | 119 | 2016 |
| Conservation of biological diversity in the Sierra Madre Mountains of Isabela and southern Cagayan Province, the Philippines F Danielsen, DS Balete, TD Christensen, M Heegaard, OF Jakobsen, ... BirdLife International, Manila and Copenhagen, 1994 | 50 | 1994 |
| Systematic review: Incidence, risk factors, survival and treatment of bone metastases from colorectal cancer TD Christensen, SG Jensen, FO Larsen, DL Nielsen Journal of bone oncology 13, 97-105, 2018 | 46 | 2018 |
| Risk factors for brain metastases in patients with metastatic colorectal cancer TD Christensen, JA Palshof, FO Larsen, E Høgdall, TS Poulsen, P Pfeiffer, ... Acta Oncologica 56 (5), 639-645, 2017 | 32 | 2017 |
| Associations between primary tumor RAS, BRAF and PIK3CA mutation status and metastatic site in patients with chemo-resistant metastatic colorectal cancer TD Christensen, JA Palshof, FO Larsen, TS Poulsen, E Høgdall, P Pfeiffer, ... Acta Oncologica 57 (8), 1057-1062, 2018 | 30 | 2018 |
| Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancer D Høgdall, CJ O’Rourke, FO Larsen, S Zarforoushan, TD Christensen, ... Journal of hepatology 77 (4), 1047-1058, 2022 | 14 | 2022 |
| Expression of secretory phospholipase A2 group IIa in breast cancer and correlation to prognosis in a cohort of advanced breast cancer patients SS Jespersen, ES Stovgaard, D Nielsen, TD Christensen, ASK Buhl, ... Applied Immunohistochemistry & Molecular Morphology 29 (1), e5-e9, 2021 | 9 | 2021 |
| Blood‐based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer TD Christensen, C Jensen, O Larsen, B Leerhøy, CP Hansen, K Madsen, ... International Journal of Cancer 152 (5), 1036-1049, 2023 | 8 | 2023 |
| Protein signatures and individual circulating proteins, including IL-6 and IL-15, associated with prognosis in patients with biliary tract cancer TD Christensen, K Madsen, E Maag, O Larsen, LH Jensen, CP Hansen, ... Cancers 15 (4), 1062, 2023 | 7 | 2023 |
| Pesticide Residues A Petersen, BH Jensen, JH Andersen, ME Poulsen, T Christensen, ... Results from the Period 2011, 138, 2004 | 7 | 2004 |
| Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective … ASK Buhl, TD Christensen, IJ Christensen, KM Nelausen, E Balslev, ... Breast Cancer Research and Treatment 172, 391-400, 2018 | 6 | 2018 |
| Determination of temporal reproducibility and variability of cancer biomarkers in serum and EDTA plasma samples using a proximity extension assay TD Christensen, E Maag, K Madsen, SC Lindgaard, DL Nielsen, ... Clinical Proteomics 19 (1), 39, 2022 | 5 | 2022 |
| Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer TD Christensen, E Maag, O Larsen, CL Feltoft, KR Nielsen, LH Jensen, ... JHEP reports 5 (3), 100648, 2023 | 4 | 2023 |
| Prediction of fulvestrant efficacy in patients with advanced breast cancer: retrospective-prospective evaluation of the predictive potential of a multigene expression assay TD Christensen, ASK Buhl, IJ Christensen, IK Buhl, E Balslev, AS Knoop, ... Breast Cancer 27, 266-276, 2020 | 3 | 2020 |
| Risk factors for brain metastases in patients with metastatic colorectal cancer TD Christensen, JA Palshof, FO Larsen, E Høgdall, TS Poulsen, ... Annals of Oncology 27, vi192, 2016 | 2 | 2016 |
| Fulvestrant response prediction from transcriptome data obtained from primary breast cancer biopsies. TD Christensen, ASK Buhl, IJ Christensen, KM Nelausen, E Balslev, ... Journal of Clinical Oncology 34 (15_suppl), e12056-e12056, 2016 | 2 | 2016 |
| Circulating immune-related proteins associated with immune checkpoint inhibitor efficacy in patients with pancreatic ductal adenocarcinoma TD Christensen, E Maag, S Theile, K Madsen, SC Lindgaard, ... ESMO open 9 (6), 103489, 2024 | 1 | 2024 |
| Prediction of exemestane benefit in patients with advanced breast cancer based on diagnostic biopsy mRNA analysis. TD Christensen, ASK Buhl, IJ Christensen, KM Nelausen, E Balslev, ... Journal of Clinical Oncology 35 (15_suppl), e12532-e12532, 2017 | 1 | 2017 |
| Circulating protein-based biomarkers in biliary tract cancer TD Christensen | | 2023 |
| Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer. Cancers 2023, 15, 1062 TD Christensen, K Madsen, E Maag, O Larsen, LH Jensen, CP Hansen, ... | | 2023 |
